A class action lawsuit has been initiated against Picard Medical, Inc. (NYSE: PMI) alleging violations of federal securities laws. The complaint contends that the company and potentially related parties engaged in fraudulent practices including the dissemination of false statements to investors and coordinated insider share sales during a period of artificially inflated stock prices.
According to court filings, the alleged scheme involved the use of social media platforms to promote misleading information about the company's business and prospects. During the period in question, insiders are alleged to have sold substantial share holdings while the stock price was maintained at elevated levels through these promotional activities.
Investors who purchased Picard Medical securities between September 2, 2025 and October 31, 2025 may have standing to participate in the litigation. The deadline to file a claim or serve as lead plaintiff in the case is April 3, 2026. Eligible shareholders are encouraged to consult with legal counsel regarding their potential claims and the procedural requirements for joining the action.